IBM and CLC Bio deliver turnkey genomics sequencing analytics solution (IBM branded)

IBM and CLC bio have undertaken a joint effort to develop the CLC bio/IBM Genomics Analytics Solution, a turnkey next-generation sequencing (NGS) platform. The system was built for practitioners, requiring little IT administration, yet it is scalable, flexible and extendable.